News story
Thousands of patients to benefit from life-saving COVID-19 treatment
Ground-breaking new treatment to be rolled out to vulnerable hospital patients from next week
Thousands of vulnerable NHS patients in hospital due to COVID-19 are set to benefit from a ground-breaking new antibody treatment, the government has announced today (17 September 2021).
Ronapreve, a combination of two monoclonal antibodies, will be targeted initially at those in hospital who have not mounted an antibody response against COVID-19.
This includes people who are immunocompromised, for example those with certain cancers or autoimmune diseases, and therefore have difficulty building up an antibody response to the virus, either through being exposed to COVID-19 or from vaccination.
And when that fails, there is always the ECMO system to bypass failed lungs.
[theguardian.com]
Best wishes to the people in Alberta.
@Naomi Thanks, we need all the help we can get after the government listened to those who wanted the Summer Open.